Inventor · disambiguated record
Michael Bardroff
Also filed as: BARDROFF MICHAEL · BARDROFF MICHAEL OTTO
12 granted patents·12 pending applications·140 citations·filing 2003–2024
90Inventor score
Top patents by PatentIndex Score
24 records- 0195US7794719B2Anti-amyloid β antibodiesHOFFMANN LA ROCHE·Filed 2003·Granted Sep 14, 2010·77 cites·9 claims
- 0292US9376489B2IL-18 binding moleculesBARDROFF MICHAEL OTTO·Filed 2013·Granted Jun 28, 2016·14 cites·25 claims
- 0392US8329886B2Nucleic acid molecules encoding anti-amyloid beta antibodiesBARDROFF MICHAEL·Filed 2012·Granted Dec 11, 2012·22 cites·33 claims
- 0490US8216577B2Anti-Aβ antibodies and their useBARDROFF MICHAEL·Filed 2009·Granted Jul 10, 2012·14 cites·12 claims
- 0587US2025034240A1Il-18 binding moleculesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0683US11111293B2IL-18 binding moleculesNOVARTIS AG·Filed 2018·Granted Sep 7, 2021·1 cites·15 claims
- 0778US8715657B2Therapeutic antibodies binding IL12Rβ1BARDROFF MICHAEL·Filed 2010·Granted May 6, 2014·5 cites·15 claims
- 0876US10081677B2IL-18 binding moleculesBARDROFF MICHAEL OTTO·Filed 2016·Granted Sep 25, 2018·1 cites·6 claims
- 0976US2022098296A1Il-18 binding moleculesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1074US8114964B2Anti-MCP-1 antibodies, compositions, methods and usesDAS ANUK·Filed 2007·Granted Feb 14, 2012·3 cites·5 claims
- 1174US2024425617A1Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodiesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1268US8673306B2Compositions and methods of use for antibodies of dickkopf-1SHULOK JANINE·Filed 2007·Granted Mar 18, 2014·2 cites·11 claims
- 1363US11987644B2Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodiesNOVARTIS AG·Filed 2020·Granted May 21, 2024·0 cites·4 claims
- 1462US9296813B2Compositions and methods of use for antibodies of Dickkopf-1SHULOK JANINE R·Filed 2014·Granted Mar 29, 2016·1 cites·19 claims
- 1557US2023357381A1Multispecific antibodies targeting il-13 and il-18NOVARTIS AG·Filed 2023·Application pending·0 cites
- 1657US2013136747A1Anti-amyloid beta antibodies and their useHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 1756US2025000973A1Methods of making chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1849US2023302155A1Compositions and methods for in vivo generation of car expressing cellsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1949US2019002589A1Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodiesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2048US8420787B2Organic compoundsBARDROFF MICHAEL·Filed 2007·Granted Apr 16, 2013·0 cites·4 claims
- 2147US2023256017A1Methods of making chimeric antigen receptor-expressing cellsBROGDON JENNIFER·Filed 2021·Application pending·0 cites
- 2247US2014248265A1Therapeutic antibodies binding il 12rbeta1BARDROFF MICHAEL OTTO·Filed 2014·Application pending·0 cites
- 2347US2014341901A1Compositions and methods of use for antibodies of dickkopf-1SHULOK JANINE R·Filed 2014·Application pending·0 cites
- 2439US2013323237A1Organic compoundsBARDROFF MICHAEL·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →